Frank Greenberg
It is now over 28 years since Dr Angelo DiGeorge' commented on a paper by Dr Max Cooper and colleagues2 regarding the congenital absence of the thymus. At the 1965 Society for Pediatric Research (SPR) meeting, Dr Cooper gave a paper showing that the lymphoid system of the chicken consisted of two different components, the bursal system and the thymic system. Ablation of the bursal system caused agammaglobulinaemia but did not affect cellular immunity. However, thymectomy impaired cellular immunity. In his comment, Dr DiGeorge noted that there was a group of infants with congenital absence of the thymus who might represent a human homologue of the thymectomised chicks. DiGeorge and his co-worker, Dr James Arey, had noted three infants with congenital absence of the parathyroids who also had no evidence of thymic tissue. As DiGeorge stated, "the concurrent absence of both structures is not surprising if one recognizes that both are derived from common primordia. Furthermore, this association has been previously recorded although its physiologic significance has not been recognized."' Just before the 1965 SPR meeting, DiGeorge and colleagues (Drs Harold Lischner, Catherine Dacou-Voutetakis, and Hope Punnett) were in the process of studying a fourth infant with congenital hypoparathyroidism who was predicted to have absence of the thymus. In addition to the absence of the thymic shadow on chest radiograph, the infant had abnormal cellular immunity with persistent candidiasis, negative monilial skin test, and failure to reject a homologous skin graft, although the lymphocyte count, plasma cell numbers in lymph nodes, and serum immunoglobulins were normal. The infant was also noted to be 'runted' in spite of adequate control of serum calcium levels. DiGeorge suggested that all infants with congenital hypoparathyroidism should be studied for defects in cellular immunity. This was contrary to the prevailing notion that patients with absent thymus would have normal immunoglobulins and normal total peripheral blood lymphocyte counts.
As '9 At the time of the preparation of the manuscript of Kelley et all9 I had recently arrived at Baylor College of Medicine. During my first year, I saw a patient with suspected DGA who had one previous sib who died and was noted to have DGA at necropsy. Another previous sib in Mexico died in the neonatal period from a congenital heart defect but no necropsy was done. Suspecting a chromosome 22 abnormality, I sent blood to Dr David Ledbetter's laboratory for analysis with the notation "Look at chromosome 22". The following week, David called excitedly one evening to inform me that I was right. The patient had a derivative chromosome 4 with loss of of 22ql 1. As it turned out, his mother had the same derivative chromosome 4 but was clinically normal (so it seemed). This case was mentioned as an addendum to the Kelley et al19 paper and then, subsequently, published as a separate case report. 20 The discovery of this DGA patient started me on a prospective study of cytogenetic abnormalities in DGA patients.2' Over a five year period, I was able to ascertain 28 patients with DGA. Comparisons between our prospective study and the retrospective study of Conley et 
